Template:Valproate sodium: Difference between revisions

Latest revision as of 19:48, 6 February 2014

Valproate sodium
Depacon^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Valproate sodium
ClinicalTrials.gov

@@ Line 2: / Line 2: @@
 ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Valproate sodium|{{fontcolor|#6C7B8B|Valproate sodium}}]]'''''
 |-
-! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Depakote<sup>®</sup> FDA Package Insert
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Depacon<sup>®</sup> FDA Package Insert
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Valproate sodium indications and usage|Indications and Usage]]
@@ Line 38: / Line 38: @@
 ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Valproate sodium
 |-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}ClinicalTrials.gov]
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
 |-
 |}